← Leaderboards
Robert J Parmer
University Of California San Diego
$2,470,759
Attributed
$4,459,337
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $786.1K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,459,337 · 7
VA$0 · 2
By mechanism
R01$3,406,383 · 2
P01$666,198 · 1
U01$318,627 · 1
M01$68,129 · 3
I01$0 · 2
Top collaborators
- Lindsey A Miles4 shared
- Fahumiya Samad4 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- Daniel T O'Connor$5,574,664
- Vivian Y. H. Hook$23,603,887
- Laurent Taupenot$1,672,200
- Sucheta M Vaingankar$2,726,093
- Jerrold M Olefsky$29,583,289
Others in their field
Top investigators on “Plasminogen”
- Joseph Paul Broderick · University Of Cincinnati$18,831,259
- Guy L Reed · Harvard University (Sch Of Public Hlth)$18,181,726
- Douglas Eugene Vaughan · Vanderbilt University$16,531,066
- Jeffrey L Saver · University Of California Los Angeles$16,373,833
- Daniel A Lawrence · University Of Michigan At Ann Arbor$16,210,511
- Lindsey A Miles · Scripps Research Institute$14,647,352
Research focus
PlasminogenHypertensionPathway InteractionsAffectIn VivoAdultResponseMediatingIn VitroProteinsPlasminogen ReceptorPlayRegulationPlasminPhenotypeHuman SubjectFamily GeneticsBaseFibrosisFibrinCause Of DeathFibrinogenHomeostasisEquilibrium
Grant awards (26)
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis$732,257
R01 · FY2022 · HL
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis$732,257
R01 · FY2021 · HL
Regulation of Renal Injury and Fibrosis by the Plasminogen Receptor, Plg-RKT$0
I01 · FY2021 · VA · contact PI
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis$732,257
R01 · FY2020 · HL
Regulation of Renal Injury and Fibrosis by the Plasminogen Receptor, Plg-RKT$0
I01 · FY2020 · VA · contact PI
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis$786,096
R01 · FY2019 · HL
Regulation of Renal Injury and Fibrosis by the Plasminogen Receptor, Plg-RKT$0
I01 · FY2019 · VA · contact PI
Regulation of Renal Injury and Fibrosis by the Plasminogen Receptor, Plg-RKT$0
I01 · FY2018 · VA · contact PI
Cell Surface Plasminogen Activation and Hypertension$0
I01 · FY2016 · VA · contact PI
Cell Surface Plasminogen Activation and Hypertension$0
I01 · FY2015 · VA · contact PI
Cell Surface Plasminogen Activation and Hypertension$0
I01 · FY2014 · VA · contact PI
Cell Surface Plasminogen Activation and Hypertension$0
I01 · FY2013 · VA · contact PI
RENAL DOPAMINERGIC PHARMACOGENOMICS$525
M01 · FY2006 · RR · contact PI
RENAL DOPAMINERGIC PHARMACOGENOMICS$37,854
M01 · FY2005 · RR
GENETIC HYPERTENSION$7,326
M01 · FY2005 · RR
Genetic Hypertension$22,424
M01 · FY2004 · RR
Phenotyping--pharmacodynamic renal dopaminergic responses in pedigrees$318,627
U01 · FY2002 · HL
HEREDITARY AUTONOMIC INTERMEDIATE PHENOTYPES IN HYPERTENSION$159,403
P01 · FY2002 · HL
HEREDITARY AUTONOMIC INTERMEDIATE PHENOTYPES IN HYPERTENSION$159,403
P01 · FY2002 · HL
Phenotyping--pharmacodynamic renal dopaminergic responses in pedigrees$0
U01 · FY2002 · HL
PROCESSING OF CHROMOGRANIN A BY THE FIBRINOLYTIC SYSTEM$214,888
R01 · FY2001 · HL
HEREDITARY AUTONOMIC INTERMEDIATE PHENOTYPES IN HYPERTENSION$159,403
P01 · FY2001 · HL
Phenotyping--pharmacodynamic renal dopaminergic responses in pedigrees$0
U01 · FY2001 · HL
Phenotyping--pharmacodynamic renal dopaminergic responses in pedigrees$0
U01 · FY2001 · HL
PROCESSING OF CHROMOGRANIN A BY THE FIBRINOLYTIC SYSTEM$208,628
R01 · FY2000 · HL
HEREDITARY AUTONOMIC INTERMEDIATE PHENOTYPES IN HYPERTENSION$187,989
P01 · FY2000 · HL